In January of this year, the national hospital alliance Premier Inc. announced the winners of its contract for clinical chemistry. The contract had been particularly important because it would cover all of Premier's 1,800 member hospitals, or about a third of hospitals in the US. Moreover, only one chemistry company would win—so bidders cut prices to the bone, figuring to make their money back on volume. But instead of choosing one supplier, Premier chose three, giving it the best of both worlds—heavy discounts and a choice of vendors.
Upset over the process and the pricing, each of the three winners, Johnson & Johnson Clinical Diagnostics, Corange Ltd.subsidiary Boehringer...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?